This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Richard J. Rickles: Innovator in Cancer Treatment
Introduction
Richard J. Rickles is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work primarily focuses on combination therapies that enhance the effectiveness of cancer treatments.
Latest Patents
Rickles holds a patent for a groundbreaking invention titled "Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers." This patent outlines a novel approach that combines an MDM2 inhibitor with additional pharmaceutical agents to improve cancer treatment outcomes. The invention also includes pharmaceutical compositions that utilize this combination therapy.
Career Highlights
Rickles has dedicated his career to advancing cancer therapies. His innovative approach has the potential to change the landscape of cancer treatment, providing new hope for patients. With a patent count of 1 patent, he continues to push the boundaries of medical science.
Collaborations
Throughout his career, Rickles has collaborated with esteemed colleagues, including Sean Caenepeel and Jude Robert Canon. These partnerships have fostered a collaborative environment that enhances the development of effective cancer therapies.
Conclusion
In summary, Richard J. Rickles is a pioneering inventor whose work in combination therapies for cancer treatment is making a significant impact. His innovative approaches and collaborations are paving the way for advancements in the fight against cancer.